Bavarian Nordic Announces Additional Positive Data from a Phase 2 Study of its Universal RSV Vaccine Pharmaceutical Investing
3D Signatures and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec Announce Collaboration Genetics Investing
Aduro Announces Milestone Achieved under Merck Collaboration for Initiation of Anti-CD27 Phase I Trial in Advanced Solid Tumors Biotech Investing
Anthera Pharmaceuticals Provides Business Update and Reports 2017 Fourth Quarter and Fiscal Year Financial Results Pharmaceutical Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
